Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure: A Randomized Clinical Trial With 1-Year Follow-up

NCT07543315 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07543315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07543315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Versus High Dose OnabotulinumtoxinA for Chronic Anal Fissure: A Randomized Clinical Trial With 1-Year Follow-up
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Completed
Start date
August 1, 2023
Completion date
August 30, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic anal fissure